Ustekinumab Spirig HC 45 mg / 0.5 ml

Ustekinumab Spirig HC 45 mg / 0.5 ml is a medicine authorised by Swissmedic under authorisation number 69304. The authorisation holder is Spirig HealthCare AG. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 06 November 2024 and the authorisation is limited until 05 November 2029. ATC code L04AC05 places the medicine in the group Immunosuppressants.

  • Dispensing category B
  • Authorisation number 69304
  • ATC L04AC05
  • Biotechnological medicines
Authorisation data
Authorisation number69304
NameUstekinumab Spirig HC 45 mg / 0.5 ml
Full nameUstekinumab Spirig HC 45 mg / 0.5 ml, Injektionslösung in einer Fertigspritze
Authorisation holderSpirig HealthCare AG
Medicinal product codeBiotechnological medicines
Dispensing categoryB · Prescription only
ATC codeL04AC05
First authorisation06 November 2024
Authorisation validity05 November 2029
Strengths
No.NameDispensing categoryAuthorisation date
1Ustekinumab Spirig HC 45 mg / 0.5 ml, Injektionslösung in einer FertigspritzeB06 November 2024
2Ustekinumab Spirig HC 90 mg / 1 ml, Injektionslösung in einer FertigspritzeB06 November 2024

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
31Fertigspritze(n)L04AC0507.15.0.B
41Fertigspritze(n)L04AC0507.15.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Ustekinumab Spirig HC 45 mg / 0.5 ml authorised in Switzerland?

Yes. Ustekinumab Spirig HC 45 mg / 0.5 ml is authorised by Swissmedic under authorisation number 69304, data as of 01 September 2026. The authorisation is limited until 05 November 2029.

Which dispensing category does Ustekinumab Spirig HC 45 mg / 0.5 ml have?

Ustekinumab Spirig HC 45 mg / 0.5 ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Ustekinumab Spirig HC 45 mg / 0.5 ml?

The authorisation holder is Spirig HealthCare AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com